• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化的基因治疗:精准医学的新工具。

Gene therapy for cystic fibrosis: new tools for precision medicine.

机构信息

Program in Developmental and Stem Cell Biology, Hospital for Sick Children, 686 Bay Street, PGCRL 16-9420, Toronto, ON, M5G0A4, Canada.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

出版信息

J Transl Med. 2021 Oct 30;19(1):452. doi: 10.1186/s12967-021-03099-4.

DOI:10.1186/s12967-021-03099-4
PMID:34717671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8556969/
Abstract

The discovery of the Cystic fibrosis (CF) gene in 1989 has paved the way for incredible progress in treating the disease such that the mean survival age of individuals living with CF is now ~58 years in Canada. Recent developments in gene targeting tools and new cell and animal models have re-ignited the search for a permanent genetic cure for all CF. In this review, we highlight some of the more recent gene therapy approaches as well as new models that will provide insight into personalized therapies for CF.

摘要

1989 年囊性纤维化(CF)基因的发现为治疗该病带来了令人难以置信的进展,使得现在加拿大 CF 患者的平均存活年龄约为 58 岁。基因靶向工具的最新发展以及新型细胞和动物模型重新点燃了寻找所有 CF 永久基因治疗方法的研究热情。在这篇综述中,我们重点介绍了一些最近的基因治疗方法以及新的模型,这些将为 CF 的个性化治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/1d57a3053587/12967_2021_3099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/4df4e826bf95/12967_2021_3099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/882648850096/12967_2021_3099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/25dc8171464d/12967_2021_3099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/1d57a3053587/12967_2021_3099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/4df4e826bf95/12967_2021_3099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/882648850096/12967_2021_3099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/25dc8171464d/12967_2021_3099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9d/8556969/1d57a3053587/12967_2021_3099_Fig4_HTML.jpg

相似文献

1
Gene therapy for cystic fibrosis: new tools for precision medicine.囊性纤维化的基因治疗:精准医学的新工具。
J Transl Med. 2021 Oct 30;19(1):452. doi: 10.1186/s12967-021-03099-4.
2
A new era of personalized medicine for cystic fibrosis - at last!囊性纤维化个性化医疗的新时代——终于到来了!
Can Respir J. 2015 Sep-Oct;22(5):257-60. doi: 10.1155/2015/921712. Epub 2015 Jun 17.
3
Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.囊性纤维化个体化医学:从调节剂开发到治疗罕见 CFTR 突变的囊性纤维化患者。
Am J Physiol Lung Cell Mol Physiol. 2018 Apr 1;314(4):L529-L543. doi: 10.1152/ajplung.00465.2017. Epub 2017 Dec 14.
4
Changing the Paradigm - Treating the Basic Defect in Cystic Fibrosis.改变范式——治疗囊性纤维化的基本缺陷
Indian J Pediatr. 2015 Aug;82(8):727-36. doi: 10.1007/s12098-015-1786-3. Epub 2015 Jun 17.
5
Translational research to enable personalized treatment of cystic fibrosis.将转化研究用于囊性纤维化的个体化治疗。
J Cyst Fibros. 2018 Mar;17(2S):S46-S51. doi: 10.1016/j.jcf.2017.10.017. Epub 2017 Dec 21.
6
Translating the genetics of cystic fibrosis to personalized medicine.将囊性纤维化的遗传学应用于个性化医疗。
Transl Res. 2016 Feb;168:40-49. doi: 10.1016/j.trsl.2015.04.008. Epub 2015 Apr 15.
7
Genome Editing for Cystic Fibrosis.基因组编辑治疗囊性纤维化。
Cells. 2023 Jun 6;12(12):1555. doi: 10.3390/cells12121555.
8
Cystic fibrosis - an example of personalized and precision medicine.囊性纤维化——个性化与精准医学的一个例子。
APMIS. 2019 May;127(5):352-360. doi: 10.1111/apm.12915. Epub 2019 Feb 14.
9
Advances in gene therapy for cystic fibrosis lung disease.囊性纤维化肺病的基因治疗进展。
Hum Mol Genet. 2019 Oct 1;28(R1):R88-R94. doi: 10.1093/hmg/ddz139.
10
Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date.囊性纤维化跨膜电导调节因子调节剂在囊性纤维化个体化药物治疗中的应用:最新进展。
Drugs. 2010 Feb 12;70(3):241-59. doi: 10.2165/11316160-000000000-00000.

引用本文的文献

1
Evolution and Prognostic Variables of Cystic Fibrosis in Children and Young Adults: A Narrative Review.儿童和青年囊性纤维化的演变及预后变量:一项叙述性综述
Diagnostics (Basel). 2025 Aug 2;15(15):1940. doi: 10.3390/diagnostics15151940.
2
Organoid-on-a-chip (OrgOC): Advancing cystic fibrosis research.芯片上的类器官(OrgOC):推动囊性纤维化研究。
Mater Today Bio. 2025 Jul 28;34:102148. doi: 10.1016/j.mtbio.2025.102148. eCollection 2025 Oct.
3
Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives.单基因疾病的质粒基因治疗:挑战与展望

本文引用的文献

1
Lentiviral vectors transduce lung stem cells without disrupting plasticity.慢病毒载体转导肺干细胞而不破坏其可塑性。
Mol Ther Nucleic Acids. 2021 Jun 24;25:293-301. doi: 10.1016/j.omtn.2021.06.010. eCollection 2021 Sep 3.
2
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.评估基于 CRISPR 的 Prime 编辑在类器官癌症建模和 CFTR 修复中的应用。
Life Sci Alliance. 2021 Aug 9;4(10). doi: 10.26508/lsa.202000940. Print 2021 Oct.
3
Production of CFTR-ΔF508 Rabbits.囊性纤维化跨膜传导调节因子-ΔF508兔的培育
Pharmaceutics. 2025 Jan 14;17(1):104. doi: 10.3390/pharmaceutics17010104.
4
Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights.推进对抗囊性纤维化的战斗:干细胞与基因治疗见解
Curr Med Sci. 2024 Dec;44(6):1155-1174. doi: 10.1007/s11596-024-2936-5. Epub 2024 Dec 16.
5
Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy.用于肺部基因治疗的脂质纳米颗粒的人工智能引导设计
Nat Biotechnol. 2024 Dec 10. doi: 10.1038/s41587-024-02490-y.
6
The ageing of people living with cystic fibrosis: what to expect now?囊性纤维化患者的老龄化:现在有哪些预期?
Eur Respir Rev. 2024 Oct 30;33(174). doi: 10.1183/16000617.0071-2024. Print 2024 Oct.
7
Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical Application.用于胎儿生长受限和子痫前期的胎盘基因治疗:临床前研究及临床应用前景
J Clin Med. 2024 Sep 23;13(18):5647. doi: 10.3390/jcm13185647.
8
Genetics and precision genomics approaches to pulmonary hypertension.遗传学和精准基因组学在肺动脉高压中的应用。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01370-2024. Print 2024 Oct.
9
Current and future therapeutic approaches of CFTR and airway dysbiosis in an era of personalized medicine.个性化医疗时代CFTR与气道微生物失调的当前及未来治疗方法
J Family Med Prim Care. 2024 Jun;13(6):2200-2208. doi: 10.4103/jfmpc.jfmpc_1085_23. Epub 2024 Jun 14.
10
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.革新胃肠道疾病管理:前沿进展与未来前景
J Clin Med. 2024 Jul 8;13(13):3977. doi: 10.3390/jcm13133977.
Front Genet. 2021 Jan 22;11:627666. doi: 10.3389/fgene.2020.627666. eCollection 2020.
4
A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated Decay.一种新型的囊性纤维化G542X CFTR大鼠模型对无义介导的mRNA降解敏感。
Front Physiol. 2020 Dec 16;11:611294. doi: 10.3389/fphys.2020.611294. eCollection 2020.
5
Animal and Cell Culture Models for Cystic Fibrosis: Which Model Is Right for Your Application?动物和细胞培养模型在囊性纤维化研究中的应用:哪种模型适合您的应用?
Am J Pathol. 2021 Feb;191(2):228-242. doi: 10.1016/j.ajpath.2020.10.017. Epub 2020 Nov 21.
6
P.F508del editing in cells from cystic fibrosis patients.囊性纤维化患者细胞中的 P.F508del 编辑。
PLoS One. 2020 Nov 11;15(11):e0242094. doi: 10.1371/journal.pone.0242094. eCollection 2020.
7
In Vitro and In Vivo Development of the Human Airway at Single-Cell Resolution.单细胞分辨率下人类气道的体外和体内发育
Dev Cell. 2020 Sep 28;54(6):818. doi: 10.1016/j.devcel.2020.09.012.
8
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.CFTR 靶向治疗:囊性纤维化的最新进展及在其他气道疾病中的可能性。
Eur Respir Rev. 2020 Jun 16;29(156). doi: 10.1183/16000617.0068-2019. Print 2020 Jun 30.
9
A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations.一种依赖辅助病毒的腺病毒载体可将囊性纤维化上皮细胞中携带I类突变的CFTR拯救至野生型功能水平。
Eur Respir J. 2020 Nov 12;56(5). doi: 10.1183/13993003.00205-2020. Print 2020 Nov.
10
Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction.高效编辑囊性纤维化患者气道基底细胞中的基因可实现功能性 CFTR 纠正。
Mol Ther. 2020 Jul 8;28(7):1684-1695. doi: 10.1016/j.ymthe.2020.04.021. Epub 2020 Apr 29.